Clinical trial · Interventional
Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
MK III Trial: Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
NCT00224692CI-TRIAL-00000489terminatedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hypothesis : Low dose ketamine has an analgesic effect in children with mucositis treated by patient-controlled analgesia with morphine
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Mucositis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low dose ketamine | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pain score
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Painful mucositis * Child from 5 to 18 years. * Presenting mucitis induced by chemotherapy or a conditioning of graft hematopoïetic. * A pain not controlled by systematic paracetamol (10mg/kg/4h) or a the propacetamol (20mg/kg/4h). * Not presenting a neurological or psychological difficulty at the use of the PCA or a EVA. * First morphine amount going back to less 48h, and lass administration dating of more than 4h at the time of the beginning of the perfusion of Ketamine/placebo (EVA \> 30 after stop morphine). * Assent signed by the parents and each time possible by the child. Exclusion Criteria: * The child was already included in the study. * The age of psychomotor development is lower than 5 years * Presence of a depression or a major depressive episode according to definition DSM IV. * Hepatic or renal anomaly major (rank 3 or 4 of the scale of toxicity NCI CTC v2.0) * Bilirubin\>3N * Gamma WP\>3N * SGOT or SGPT \>5N * Creatinin\>3N
References
Publications (0)
Data not yet available
No reference posted for this study.